v3.26.1
ORGANIZATION, LIQUIDITY AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative)
12 Months Ended
Mar. 31, 2026
USD ($)
Integer
shares
Mar. 31, 2025
USD ($)
shares
Cash and Cash Equivalents [Line Items]    
Accumulated deficit $ 175,106,286 $ 167,954,817
Net loss (7,151,469) (13,388,089)
Cash balances over insured amount 384,000  
Cash equivalents of US treasury bills 4,400,000  
Restricted cash 98,928 97,813
Uncertain tax positions 0 0
Asset impairment charges $ 0 $ 0
Antidilutive shares | shares 1,958,149 293,817
Research and development expenses $ 1,912,000 $ 2,212,000
Australian research and development expense $ 218,000  
Number of Reportable Segments | Integer 1  
Letter of Credit [Member]    
Cash and Cash Equivalents [Line Items]    
Restricted cash $ 87,506  
JP Morgan Chase [Member]    
Cash and Cash Equivalents [Line Items]    
Converted to money market deposit account $ 5,000